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Abstract
Background: Pediatric rheumatic diseases are chronic illnesses that can cause considerable disease burden to
children and their families. There is limited epidemiologic data on these diseases in East Africa. The aim of this
study was to assess the spectrum of pediatric rheumatic diagnoses in an in-patient setting and determine the
accuracy of ICD-10 codes in identifying these conditions.
Methods: Medical records from Gertrude’s Children’s Hospital in Kenya were reviewed for patients diagnosed with
“diseases of the musculoskeletal system and connective tissue” as per ICD-10 diagnostic codes assigned at
discharge between January and December 2011. Cases were classified as “rheumatic” or “non-rheumatic”. Accuracy
of the assigned ICD-10 code was ascertained. Death records were reviewed. Longitudinal follow-up of “rheumatic”
cases was done by chart review up to March 2014.
Results: Twenty six patients were classified as having a “rheumatic” condition accounting for 0.32% of patients
admitted. Of these, 11 (42.3%) had an acute inflammatory arthropathy, 6 (23.1%) had septic arthritis, 4 (15.4%) had
Kawasaki disease, 2 (7.7%) had pyomyositis, and there was one case each of septic bursitis, rheumatic fever, and a
non-specific soft tissue disorder. No cases of juvenile idiopathic arthritis (JIA) were identified. One case of systemic
lupus erythematosus was documented by death records. The agreement between the treating physician’s
discharge diagnosis and medical records ICD-10 code assignment was good (Kappa: 0.769). On follow-up, one child
had recurrent knee swelling that was suspicious for JIA.
Conclusions: Pediatric rheumatic conditions represented 0.32% of admissions at a pediatric hospital in Kenya.
Acute inflammatory arthropathies, septic arthritis and Kawasaki disease were the most frequent in-patient rheumatic
diagnoses. Chronic pediatric rheumatic diseases were rare amongst this in-patient population. Despite limitations
associated with the use of administrative diagnostic codes, they can be a first step in evaluating the spectrum of
pediatric rheumatic conditions in Kenya and other countries in East Africa.
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Background
Pediatric rheumatic diseases are chronic illnesses that
can cause considerable disease burden to children and
their families. They are associated with the potential for
physical disability, diminished quality of life and signifi-
cant direct and indirect costs [1–3]. This underscores
the importance of early diagnosis and treatment.
One of the aims of the “Bone and Joint Decade”
(2000–2010) was to increase the recognition and under-
standing of the impact of musculoskeletal conditions
throughout the world and to improve health-related
quality of life for patients living with these conditions
[4, 5]. Understanding the burden of pediatric rheumatic
diseases is a critical first step in developing and imple-
menting policies to improve patient outcomes. Multiple
studies suggest that pediatric rheumatic conditions are
not rare in Africa [6–11] yet there are limited data avail-
able from epidemiological studies. Although children
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represent 53% of the Kenyan population (38.5 million in
2010) [12], the spectrum and frequency of pediatric
rheumatic disorders remains to be defined.
We undertook this study to assess the spectrum of
pediatric rheumatic diagnoses among children hospital-
ized in 2011 at Gertrude’s Children’s Hospital (GCH) in
Kenya and to determine the accuracy of the use of mus-




GCH is a private, not-for-profit hospital located in
Nairobi, the capital of Kenya. The hospital serves the
population of Nairobi and its environs with a combined
population of approximately 4 million people [12]. It is a
tertiary level hospital with a bed capacity of 103, an emer-
gency department and 24 subspecialty clinics ranging
from cardiology, neurology, pulmonology, dermatology,
orthopedics etc. At the time this study was conducted,
there were no pediatric rheumatologists in Kenya. GCH
was selected because it is one of the largest pediatric cen-
ters in East Africa, it is the only dedicated pediatric hos-
pital in Nairobi and it has an electronic medical record
system that was implemented at the end of 2010.
At GCH, the primary physician makes a final diagnosis
at discharge. Trained medical records’ clerks assign an
International Classification of Disease 10th edition (ICD-
10) code based on the physician’s discharge diagnosis.
Study procedures
Following ethical approval from the Institutional Review
Boards of McGill University (Montreal, Canada) and
Gertrude’s Children’s Hospital (Nairobi, Kenya), a retro-
spective cross-sectional study was undertaken. Medical
records of patients diagnosed with “diseases of the mus-
culoskeletal system and connective tissue” as per ICD-10
diagnostic codes (M00 to M99, “M-codes”) at discharge
between January 1st and December 31st 2011 were iden-
tified by the electronic medical records system and se-
lected for review. For in-patients, only the discharge
diagnosis is recorded electronically. Data from the
patient’s history, clinical examination, laboratory and
microbiology investigations were extracted (AM) from
paper charts using a structured case report form. After
assessing the clinical information of each case, two rheu-
matologists (RS-pediatric rheumatologist and IC) classi-
fied cases as having a “rheumatic” condition if they had
a chronic rheumatic disease; or if they had an acute in-
flammatory or infectious condition involving the joints,
bursae, muscles, or ligaments. All other cases were con-
sidered “non-rheumatic”. Any discrepancies between the
two rheumatologists were resolved by consensus.
For the “rheumatic” cases, we assessed the agreement
between the ICD-10 code at discharge assigned by the
medical records’ clerks with the discharge diagnosis
given to the patient by the treating physician. In
addition, we report the agreement between the diagnosis
assigned by the treating physician at discharge and that
considered by the rheumatologists upon chart review.
In addition, the medical records of all in-patients who
died at GCH between January and December 2011were
reviewed to ascertain if there were any fatal “musculo-
skeletal system and connective tissue” cases, which may
not have been identified by the electronic medical record
system. As well, to assess whether any of the patients di-
agnosed with a “rheumatic” condition in 2011 pro-
gressed to develop a chronic inflammatory disease,
longitudinal follow-up of “rheumatic” cases was done by
chart review up to March 2014 by a pediatric rheuma-
tologist (RS).
Statistics
Descriptive statistics were used. Kappa coefficients were
reported to quantify the degree of agreement between
the diagnoses given by the GCH treating physician, med-
ical records’ clerks and rheumatologists.
Results
In 2011, there were a total of 8011 admissions at GCH
of which 45 were assigned an “M-code” at discharge
(Fig. 1). The medical records of 44 cases were reviewed
(1 chart could not be retrieved). From the information
documented in the medical records, 3 were misassigned
as an “M-code”, 15 were classified as “non-rheumatic”
and 26 were classified as having a “rheumatic” condition.
The chart that could not be retrieved had a discharge
diagnosis of scoliosis and would have likely been consid-
ered “non-rheumatic”.
Of the charts reviewed, surgical cases accounted for 7 of
the “non-rheumatic” conditions. Examples of these in-
cluded ganglion and dermoid cyst excisions. From the non-
surgical “non-rheumatic” conditions, examples included
musculoskeletal pain from sickle cell crises, neck pain from
suspected meningitis, and torticollis from a viral infection.
Only one patient was identified as being HIV positive; the
patient with neck pain from suspected meningitis.
“Rheumatic” conditions accounted for 0.32% of the in-
patient admissions at GCH in 2011. The median age of the
“rheumatic” patients was 3 years (range: 3 months –
15 years); 58% (15/26) were male. “Rheumatic” diagnoses
included: acute inflammatory arthropathies (n = 11, 42.3%),
septic arthritis (n = 6, 23.1%), Kawasaki disease (KD) (n = 4,
15.4%), pyomyositis (n = 2, 7.7%), septic bursitis (n = 1,
3.8%), rheumatic fever (n = 1, 3.8%) and non-specific soft
tissue disorder (n = 1, 3.8%). In the patients with an
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inflammatory arthropathy, HIV or TB arthritis was not
suspected by the treating physicians.
The agreement between the ICD-10 code assigned by
the medical records’ clerk and that of the treating phys-
ician for “rheumatic” conditions was 76.9% (20/26; Kappa:
0.769). The agreement between the ICD-10 code assigned
by the treating physician and that given by the rheuma-
tologist upon the medical record’s review for the “rheum-
atic” conditions was 84.6% (22/26; Kappa: 0.846). Perfect
agreement was found between the clerk, treating physician
and rheumatologist in cases of KD, rheumatic fever and
pyomyositis (Table 1).
The charts of the 26 patients deemed to have a
“rheumatic” condition were reviewed again in March
2014 to assess if any had progressed to develop a
chronic inflammatory disease on follow-up. Only one
patient had a recurrent episode of knee swelling suspi-
cious for the diagnosis of juvenile idiopathic arthritis
(JIA). No other patients had a chronic disease course.
The discharge diagnosis of the child with suspected JIA
was “reactive arthritis versus septic arthritis”. Upon ini-
tial chart review, and before the longitudinal follow-up,
the patient had been categorized as an “acute inflamma-
tory arthropathy” for this study.
From the 46 in-patient deaths from 2011, 45 charts
were available and each was reviewed in detail. From this
review, only 1 patient with a “rheumatic” condition was
identified. This patient had systemic lupus erythemato-
sus (SLE) and had died from sepsis. This patient had
two admissions in 2011 and the discharge diagnosis
assigned by the treating physician was “SLE”. However
the medical records’ clerk had not assigned an “M-code”
for either admissions and thus the electronic medical
record system had not identified these admissions in the
2011 search.
Discussion
Rheumatic conditions accounted for 0.32% of all admis-
sions at GCH in 2011. Acute inflammatory arthropathies
were the most common in-patient “rheumatic” diagnoses
accounting for 42.3% of all “rheumatic” cases. These pa-
tients had a short duration of symptoms, suggesting a
post-infectious etiology. No cases of JIA requiring ad-
mission were identified during the study period. Septic
arthropathies and pyomyositis combined were as com-
mon as the inflammatory arthropathies. KD was the only
vasculitis diagnosed and accounted for 15.4% of the
“rheumatic” cases. One case of SLE was identified, but
only when the death records were reviewed. This sug-
gests the possibility that other patients with “rheumatic”
conditions may have been missed due to administrative
errors in diagnostic code assignment.
The follow-up chart review, performed in 2014 to as-
sess the evolution of the 26 “rheumatic” cases identified
in 2011, confirmed that only one patient had a chronic
disease course with recurrent episodes of knee swelling
suspicious for the diagnosis of JIA. However, this does
Fig. 1 Spectrum of Pediatric Rheumatic Conditions
Table 1 Agreement between Rheumatic Diagnoses assigned by









n (%) = 20/26 (76.9%) n (%) = 22/26 (84.6%)
Inflammatory
Arthropathies (11)
8 (72.73) 9 (81.82)
Septic Arthritis (6) 4 (66.67) 5 (83.33)
Kawasaki Disease (4) 4 (100) 4 (100)
Pyomyositis (2) 2 (100) 2 (100)
Septic Bursitis (1) 0 (0) 0 (0)
Rheumatic Fever (1) 1 (100) 1 (100)
Non-Specific Soft
Tissue Disorder (1)
1 (100) 1 (100)
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not exclude the possibility that some of these patients
were followed elsewhere. This is a limitation of a retro-
spective study.
The male predominance of the “rheumatic” cases
(58%) reflects the disease entities seen in this study.
Chronic rheumatic diseases such as JIA and SLE are
more common among females however, these diseases
were not found in this in-patient population and there-
fore a female predominance should not be expected. All
3 cases of pyomyositis and septic bursitis were male.
These entities are more commonly seen post-trauma
which would be expected to be more frequent in males.
As well, KD is slightly more common in males and in
this study, 3 of the 4 patients with KD were male.
In our study, there were no children admitted for JIA
and only one for SLE. This could reflect the low preva-
lence of these conditions as a cause for hospital admis-
sion, the lack of awareness / expertise of pediatricians in
diagnosing these conditions, the limited use of specific
M codes, the underestimation of the real frequency of
these diagnoses based on their ascertainment through
ICD-10 codes (i.e. coding errors) or the limitation of M-
codes in identifying multisystem diseases such as SLE.
Furthermore, an in-patient population may not be the
ideal target population to assess conditions like JIA,
which may be more likely assessed in out-patient clinics.
In this study, we chose to use M-codes to identify cases.
However it is possible, that other cases could have been
captured by the use of other specific codes (i.e. renal or
hematologic impairments for SLE) and that M-codes
underestimate the frequency of multisystem diagnoses. In
the case of SLE, despite having a specific diagnostic M-
code, discharge diagnosis may reflect the patient’s reason
for admission (i.e. renal failure) rather than the patient’s
diagnosis, which is another limitation of the use of admin-
istrative diagnostic codes to identify cases. As well, it is
important to note that misdiagnoses are difficult to cap-
ture no matter what tool is used to identify cases. For ex-
ample, if the treating physician could not identify that the
child being treated for fever, rash and pericarditis was a
child with systemic JIA and the discharge diagnosis was
pericarditis or viral illness, this case would not have been
captured. The absence of these diseases may reflect the
limitations associated with the use of administrative diag-
nostic codes to capture cases in addition to the lack of ex-
pertise of pediatricians to diagnose specific rheumatic
diseases rather than the true absence of disease.
JIA and pediatric SLE cases have been identified in
various countries across the African continent such as in
Nigeria, South Africa and Zambia [6–11]. In the Nigerian
studies, they identified 11 children with SLE who were ad-
mitted to a hospital over a 5 year period [9, 10]. The rates
reported for SLE in our study appear lower than those re-
ported in Nigeria. With regard to JIA, all previous
reported cases reflected out-patient data and thus are not
comparable.
The first pediatric case of KD was described in Africa
in 1979 [13]. In our study, four cases of KD were identi-
fied over a one year period, which is comparable, or a
bit higher, than a few of the larger African case series in
the literature [14–16]. Rheumatic fever is still the most
common cause of acquired cardiac disease in children in
developing countries [17] yet in this study, only one case
of rheumatic fever was admitted. It is possible that most
cases were managed as out-patients.
In Kenya, there is both a private and public medical
system with several private hospitals and one main pub-
lic national referral hospital that provide pediatric care
in Nairobi. In 2008, the Government of Kenya provided
resources for 48% of the country’s health care facilities,
while 49% was provided by the private sector (both for-
profit and not-for-profit) [18]. Although private, GCH is
the only dedicated pediatric hospital providing care ex-
clusively to children; whereas the other hospitals have
pediatric units. GCH has fewer but comparable in-
patient admissions as compared to the main national
public referral hospital (GCH: 8011 in 2011; public hos-
pital: 9656 in 2007) [19]. We chose to undertake this
study at GCH because it had the infrastructure to sup-
port this study particularly with the electronic medical
records system. However, given that GCH only sees
pediatric patients, it does not have access to adult
rheumatology services. It is possible that if this study
was conducted at the main public national referral hos-
pital that has both adult and pediatric units, with access
to adult rheumatology, more defined “rheumatic” cases
could have been identified. In addition, given that GCH
is a private hospital, the population that accesses it is
different socioeconomically than those who can only ac-
cess the public system.
It is important to highlight that at the time this study
was conducted, there were no pediatric rheumatologists
in Kenya. Global variability in the prevalence rates of
pediatric musculoskeletal diseases has been attributed to
varying levels of awareness of rheumatic diseases, com-
bined with the lack of personnel and infrastructure to
diagnose and manage these conditions [20]. This is par-
ticularly relevant in a setting where diverse and frequent
entities such as infections, rickets and hemoglobinopa-
thies [21] can lead to misdiagnosis and delays in the
treatment of more rare rheumatic disorders. Olowu sug-
gested that the paucity of pediatric rheumatologists, low
level of lupus awareness, malaria endemicity (since mal-
aria shares certain clinical features with lupus) contributed
to misdiagnosis of lupus in the Nigerian pediatric popula-
tion [10]. In his series, all SLE cases were misdiagnosed
prior to referral (36.4% as malaria) suggesting a low level
of awareness [10]. Prospective studies assessing rheumatic
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diagnoses made by pediatric rheumatologists now working
in Kenya will be relevant to estimate the real burden
of rheumatic conditions in this setting. We suspect
that disease awareness and the presence of pediatric
rheumatologists locally will improve case ascertain-
ment and provide more accurate estimates of the fre-
quency and spectrum of disease.
The agreement in the use of ICD-10 diagnostic codes
by the records clerks and the diagnosis of the treating
physician was good (Kappa 0.769). However there are
challenges and limitations in using administrative data-
bases in estimating disease prevalence. As expected, the
more specific the treating physician’s discharge diagno-
sis, the more accurate was the assigned code as reflected
by the 100% agreement for the diagnosis of KD. In con-
trast, the missed SLE coding likely occurred due to the
use of an acronym (“SLE”) that was not interpreted by
the medical record’s clerk. This highlights the import-
ance of promoting a clear and precise record of dis-
charge diagnoses by physicians as a way to increase the
accuracy of administrative data in estimating frequencies
of diagnostic categories.
The aim of pediatric global health priorities has been to
reduce infant and childhood mortality. Infectious diseases
and injuries account for 75% of cause-specific mortality
among children 5–14 years of age [22]. Musculoskeletal
disease only comprises 0.1% of all-cause mortality in the
same age group [22]. Therefore musculoskeletal disease
has not been considered a health priority for most African
countries. Most medical efforts have been directed to-
wards preventable diseases such as acute respiratory infec-
tions, malaria, measles, diarrhea, HIV, malnutrition and
trauma [22]. However, as preventable diseases are better
controlled and treated, there is an expected health priority
shift towards chronic conditions including rheumatic
diseases [20, 22]. Therefore the importance of rheumatic
disease awareness and building medical expertise capacity
cannot be overstated.
Conclusions
To our knowledge, this is the first report of the spectrum
of pediatric rheumatic conditions amongst in-patients in
Kenya. Pediatric rheumatic conditions represented 0.32%
of admissions at a pediatric hospital in Nairobi. Acute in-
flammatory arthropathies, septic arthritis and Kawasaki
disease were the most frequent in-patient rheumatic diag-
noses. Chronic pediatric rheumatic diseases were rare
amongst this in-patient population. This may reflect the
limitations associated with the use of administrative diag-
nostic codes and lack of expertise of pediatricians to diag-
nose specific rheumatic diseases rather than the true
absence of disease. Increasing awareness of pediatric
rheumatic diseases amongst health care professionals as
well as the recruitment of pediatric rheumatologists to the
region will allow for better identification of cases and
estimation of the burden of these diseases among
Kenyan children. Despite the limitations associated
with the use of administrative diagnostic codes, they
can be a first step in evaluating the spectrum and fre-
quency of pediatric rheumatic conditions in Kenya
and other countries in East Africa.
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